Industry News
Starpharma seeks patent for dendrimer cancer drug
Successful animal trials of dendrimer-doxorubicin have prompted Starpharma (ASX:SPL) to file for a patent for the formula in preparation for partnership negotiations. [ + ]
Prima Biomed begins recruitment in Europe
Prima BioMed (ASX:PRR) has begun recruiting patients into its ovarian cancer vaccine trial in Europe. [ + ]
Nominations invited for gene technology committees
The Office of the Gene Technology Regulator is seeking nominations for membership of the Gene Technology Technical Advisory Committee and the Gene Technology Ethics and Community Consultative Committee. [ + ]
What’s the big diff? The beamline that Australia built in Japan
After more than 20 years of service, the Australian National Beamline Facility will be retired this month and its iconic instrument, an in-vacuum diffractometer dubbed ‘Big Diff’, will head back to Australian shores. [ + ]
Waters opens solution centre in Singapore
Waters Corporation, an analytical science solutions developer and provider headquartered in Massachusetts, has announced the opening of a new solution centre in Singapore. [ + ]
Bionomics to raise $16.4m in rights issue
Bionomics (ASX:BNO) has launched a 1-for-8 rights issue to help raise cash for its drug development programs and improve its ability to independently fund clinical trials. [ + ]
Molecule may hold key to melanoma progression
The search for new pathways to treat melanoma has unearthed a molecular target that may play an important activation role in tumour growth, according to University of Newcastle researchers. [ + ]
Researchers find protein protecting against STIs
Monash Institute of Medical Research (MIMR) scientists have found a protein in the female reproductive tract that protects against sexually transmitted infections (STIs) such as chlamydia and herpes simplex virus (HSV). [ + ]
Bionomics preps for capital raising
Bionomics (ASX:BNO) has entered a trading halt ahead of a capital raising. [ + ]
Alchemia reaps $4.4m from R&D Tax Incentive
Alchemia (ASX:ACL) has received a payout under the R&D Tax Incentive scheme that has principally covered expenses related to phase III clinical trials. [ + ]
New blood test set to detect ‘forgotten’ women’s cancer
Garvan researchers, in collaboration with The Gynaecologic Cancer Centre at Royal Hospital for Women, are developing the first-ever early detection test for ovarian cancer based on epigenetic changes that are associated with ovarian cancer risk. [ + ]
Models made for science at University of Sydney exhibition
An exhibition at the University of Sydney’s Macleay Museum provides a rare opportunity to see models used to teach science and medicine at the university from the 1880s. [ + ]
Bone Therapeutics invests in cell therapy manufacturing facility
Bone Therapeutics, an international biopharmaceutical company focused on innovative cell therapy products for the treatment of bone diseases, has announced that it has secured its future manufacturing requirements, allowing it to produce its bone cell therapy products on a commercial scale. [ + ]
NSW Government funding for researchers competing for Commonwealth grants
Deputy Premier and Minister for Trade & Investment Andrew Stoner is urging NSW’s leading research centres to tap into state government funding offering them a more competitive edge in attracting lucrative Commonwealth grants. [ + ]
New workforce development service will help SMEs improve their competitive edge
A Manufacturing Workforce Development Service (MWDS) has been formed to specifically work with manufacturing SMEs to support and help them access the Australian government’s National Workforce Development Fund (NWDF). [ + ]
